Literature DB >> 12727143

Protein carbonylation in human diseases.

Isabella Dalle-Donne1, Daniela Giustarini, Roberto Colombo, Ranieri Rossi, Aldo Milzani.   

Abstract

Oxidative modifications of enzymes and structural proteins play a significant role in the aetiology and/or progression of several human diseases. Protein carbonyl content is the most general and well-used biomarker of severe oxidative protein damage. Human diseases associated with protein carbonylation include Alzheimer's disease, chronic lung disease, chronic renal failure, diabetes and sepsis. Rapid recent progress in the identification of carbonylated proteins should provide new diagnostic (possibly pre-symptomatic) biomarkers for oxidative damage, and yield basic information to aid the establishment an efficacious antioxidant therapy.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12727143     DOI： 10.1016/s1471-4914(03)00031-5

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN： 1471-4914            Impact factor:   11.951


  227 in total

Review 1.  Hyperosmolality triggers oxidative damage in kidney cells.

Authors:  Dietmar Kültz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-15       Impact factor: 11.205

Review 2.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

Authors:  Barry Halliwell; Matthew Whiteman
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

3.  Protein carbonylation in a murine model for early alcoholic liver disease.

Authors:  James J Galligan; Rebecca L Smathers; Kristofer S Fritz; L E Epperson; Lawrence E Hunter; Dennis R Petersen
Journal:  Chem Res Toxicol       Date:  2012-05-01       Impact factor: 3.739

4.  The reactivity of human serum albumin toward trans-4-hydroxy-2-nonenal.

Authors:  Qingyuan Liu; David C Simpson; Scott Gronert
Journal:  J Mass Spectrom       Date:  2012-04       Impact factor: 1.982

Review 5.  Cardiovascular redox and ox stress proteomics.

Authors:  Vikas Kumar; Timothy Dean Calamaras; Dagmar Haeussler; Wilson Steven Colucci; Richard Alan Cohen; Mark Errol McComb; David Pimentel; Markus Michael Bachschmid
Journal:  Antioxid Redox Signal       Date:  2012-08-10       Impact factor: 8.401

6.  Targeted 18O-labeling for improved proteomic analysis of carbonylated peptides by mass spectrometry.

Authors:  Mikel R Roe; Thomas F McGowan; LaDora V Thompson; Timothy J Griffin
Journal:  J Am Soc Mass Spectrom       Date:  2010-03-29       Impact factor: 3.109

7.  Accumulation of oxidized proteins in Herpesvirus infected cells.

Authors:  Shomita S Mathew; Patrick W Bryant; April D Burch
Journal:  Free Radic Biol Med       Date:  2010-05-02       Impact factor: 7.376

8.  To tag or not to tag: a comparative evaluation of immunoaffinity-labeling and tandem mass spectrometry for the identification and localization of posttranslational protein carbonylation by 4-hydroxy-2-nonenal, an end-product of lipid peroxidation.

Authors:  Jia Guo; Laszlo Prokai
Journal:  J Proteomics       Date:  2011-07-30       Impact factor: 4.044

Review 9.  Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease.

Authors:  Georgia S Gaki; Athanasios G Papavassiliou
Journal:  Neuromolecular Med       Date:  2014-02-13       Impact factor: 3.843

Review 10.  Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice-Which to Use Regarding Disease Outcomes?

Authors:  Alain Menzel; Hanen Samouda; Francois Dohet; Suva Loap; Mohammed S Ellulu; Torsten Bohn
Journal:  Antioxidants (Basel)       Date:  2021-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.